american college of cardiology

(MedPage Today) -- A Maryland plan to regulate stent procedures has elicited a push-back from local chapters of the American College of Cardiology and the Society of Cardiovascular Angiography and Interventions.

(MedPage Today) -- The American College of Cardiology and the Society of Thoracic Surgeons have joined forces to launch a registry to monitor the safety and efficacy of transcatheter aortic valve implantation (TAVI).

(MedPage Today) -- New guidelines, the result of a first-time collaboration between the American College of Cardiology and the American Heart Association, stress a multidisciplinary approach to planning interventions for patients with coronary artery disease.

Share:

(Elsevier) The American College of Cardiology and Elsevier are proud to announce that JACC: Cardiovascular Imaging has been accepted for coverage by Thomson Reuters abstracting and indexing services, including the Journal Citation Reports.

The journal will receive its first impact factor in 2011.

(University of Florida) Systolic blood pressure levels between 130 and 140 appear to be the most healthful for patients with both diabetes and coronary artery disease, according to findings from the American College of Cardiology's 59th annual scientific session in Atlanta.

High-risk patients who are not taking beta-blockers should have beta-blocker therapy started well before scheduled cardiovascular surgery, with doses titrated up as the surgery date approaches, according to updated guidelines released today by the American College of Cardiology and American Heart Association.

The following will appear in the Nov 22 issue of The Lancet:

Clinical guidelines The American College of Cardiology and American Heart Association have released the first guidelines for the treatment of adults with congenital heart disease.

These guidelines are intended to support the care of the rising number of adults with repaired heart defects, by providing comprehensive clinical information on several heart defects and highlighting key issues to look for in follow-up.

There has been quite a bit of discussion lately about how industry funding influences continuing medical education.

One of our industrious scouts pointed out one of the most recent entries in this discussion, an article on this subject by the Editor-in-Chief of the Journal of the American College of Cardiology, Dr Anthony N DeMaria [DeMaria AN.

Continuing education, industry, and physicians. J Am Coll Cardiol 2008; 52: 1035-1036. Link here.]

One of our scouts alerted me to a remarkable editorial just published by Harrison, Brown and Raggi on the ezetimibe controversy [Harrison DG, Brown WV, Raggi P.

Enhanced hype. Am J Cardiol 2008; 102: 368-369. Link here, requires subscription.]